Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study

Journal of Thrombosis and Haemostasis

Volumn 15, Issue 5, 2017, Pages 907-916

  Galanaud, J P ^a   Sevestre, M A ^b   Pernod, G ^c   Genty, C ^c   Richelet, S ^d   Kahn, S R ^e   Boulon, C ^f   Terrisse, H ^c   Quere I ^a   Bosson, J L ^c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c UNIV GRENOBLE ALPES   (France)

^d William Morey Hospital   (France)

^e MCGILL UNIVERSITY   (Canada)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

bleeding; cancer; death; deep vein thrombosis; Epidemiological studies; recurrence

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLEEDING; CANCER PATIENT; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; INCIDENCE; LONG TERM OUTCOME; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; FRANCE; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NEOPLASM; POPLITEAL VEIN; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; FRANCE; HEMORRHAGE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS; POPLITEAL VEIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 85018627435     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13664     Document Type: Article

References (25)

1. Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013; 11: 56–70.
2. Posch F, Riedl J, Reitter EM, Kaider A, Zielinski C, Pabinger I, Ay C. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model. Thromb Haemost 2016; 115: 817–26.
3. Menapace LA, McCrae KR, Khorana AA. Predictors of recurrent venous thromboembolism and bleeding on anticoagulation. Thromb Res 2016; 140(Suppl. 1): S93–8.
4. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JR, Wells P, Woller SC, Moores L. American College of Chest Physicians Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315–52.
5. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR; American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl): e419S–94S.
6. Di Nisio M, Lee AY, Carrier M, Liebman HA, Khorana AA. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2015; 13: 880–3.
7. Galanaud JP, Bosson JL, Quere I. Risk factors and early outcomes of patients with symptomatic distal vs. proximal deep-vein thrombosis. Curr Opin Pulm Med 2011; 17: 387–91.
8. Palareti G, Schellong S. Isolated distal deep vein thrombosis: what we know and what we are doing. J Thromb Haemost 2012; 10: 11–9.
9. Galanaud JP, Sevestre MA, Genty C, Kahn SR, Pernod G, Rolland C, Diard A, Dupas S, Jurus C, Diamand JM, Quere I, Bosson JL; OPTIMEV-SFMV investigators. Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost 2014; 12: 436–43.
10. Baglin T, Douketis J, Tosetto A, Marcucci M, Cushman M, Kyrle P, Palareti G, Poli D, Tait RC, Iorio A. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost 2010; 8: 2436–42.
11. Boutitie F, Pinede L, Schulman S, Agnelli G, Raskob G, Julian J, Hirsh J, Kearon C. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ 2011; 342: d3036.
12. Johnson SA, Stevens SM, Woller SC, Lake E, Donadini M, Cheng J, Labarère J, Douketis JD. Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis. JAMA 2010; 303: 438–45.
13. Bosson JL, Riachi M, Pichot O, Michoud E, Carpentier PH, Franco A. Diameters of acute proximal and distal deep venous thrombosis of the lower limbs. Int Angiol 1998; 17: 260–7.
14. Ageno W, Squizzato A, Wells PS, Buller HR, Johnson G. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost 2013; 11: 1597–602.
15. Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 2015; 13: 2119–26.
16. Ay C, Posch F, Kaider A, Zielinski C, Pabinger I. Estimating risk of venous thromboembolis in patients with cancer in the presence of competing mortality. J Thromb Haemost 2015; 13: 390–7.
17. Sartori M, Migliaccio L, Favaretto E, Palareti G, Cosmi B. Two years outcome of isolated distal deep vein thrombosis. Thromb Res 2014; 134: 36–40.
18. Li AY, Woulfe T, Rolfe-Vyson V, Rowland V, Simpson D, Merriman E. Management and outcomes of axial isolated distal deep vein thrombosis at North Shore Hospital, New Zealand: a retrospective audit. Intern Med J 2015; 45: 177–82.
19. Quere I, Righini M. Ultrasound-based diagnostic strategies for deep vein thrombosis. JAMA. 2009; 301: 933; author reply 4-5.
20. Parisi R, Visona A, Camporese G, Verlato F, Lessiani G, Antignani PL, Palareti G. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study. Int Angiol 2009; 28: 68–72.
21. Singh K, Yakoub D, Giangola P, DeCicca M, Patel CA, Marzouk F, Giangola G. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis. J Vasc Surg 2012; 55: 136–40.
22. Galanaud JP, Arnoult AC, Sevestre MA, Genty C, Bonaldi M, Guyard A, Giordana P, Pichot O, Colonna M, Quéré I, Bosson JL;OPTIMEV-SFMV Investigators. Impact of anatomical location of lower limb venous thrombus on the risk of subsequent cancer. Thromb Haemost 2014; 112: 1129–36.
23. van der Hulle T, den Exter PL, van den Hoven P, van der Hoeven JJ, van der Meer FJ, Eikenboom J, Huisman MV, Klok FA. Cohort study on the management of cancer-associated venous thromboembolism aimed at the safety of stopping anticoagulant therapy in patients cured of cancer. Chest 2016; 149: 1245–51.
24. Dentali F, Pegoraro S, Barco S, di Minno MN, Mastroiacovo D, Pomero F, Lodigiani C, Bagna F, Sartori M, Barillari G, Mumoli N, Napolitano M, Passamonti S, Benedetti R, Ageno W, Nisio MD. OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study. Thromb Res 2016; 140(Suppl. 1): S168.
25. Righini M, Galanaud JP, Guenneguez H, Brisot D, Diard A, Faisse P, Barrelier MT, Hamel-Desnos C, Jurus C, Pichot O, Martin M, Mazzolai L, Choquenet C, Accassat S, Carrier M, LeGal G, Mermillod B, Laroche J-P, Bounameaux H, Perrier A, et al. Anticoagulant therapy for symptomatic distal deep vein thrombosis: the cact us randomized placebo-controlled trial. Lancet Haematol 2016; 3: e556–62.